Brief: Prescient Therapeutics Says FY Net Loss After Tax A$7.0 Mln
25/08/2023 02:29
Aug 25 (Reuters) - Prescient Therapeutics Ltd PTX.AX :
* FY NET LOSS AFTER TAX A$7.0 MILLION VERSUS LOSS A$5.1
MILLION
Source text for Eikon: ID:nASX6tJkyF
Further company coverage: PTX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prescient Therapeutics
See all newsAustralia's Prescient Therapeutics falls on discounted share placement
Brief: Prescient Therapeutics Raises A$4.8 Million Via SPP, A$1.2 Million In Placement
Brief: Prescient Therapeutics Says Trading Halt Requested
Australia's Prescient Therapeutics hits near 2-month low on discounted raise
Brief: Prescient Therapeutics Secures EU Authorisation To Commence PTX-100 Clinical Trial